SCHEMBL1318286

SCHEMBL1318286

COC(=O)c1cc(N2CCOCC2)ccc1OCc1ccccc1

nearest known ligand 0.64

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LRRK2 Q5S007 10/20 0.64
CYP3A4 P08684 2/20 0.64
SLCO1B1 Q9Y6L6 2/20 0.64
MRGPRX4 Q96LA9 1/20 0.59
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
KDM4E B2RXH2 2/20 0.52
APP P05067 1/20 0.52
HPGD P15428 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
HTR6 P50406 1/20 0.51
HSD17B10 Q99714 1/20 0.50
KCNH2 Q12809 1/20 0.50
ALDH1A1 P00352 1/20 0.48
GAA P10253 1/20 0.48
MAPT P10636 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
NPC1 O15118 1/20 0.48
RAB9A P51151 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL552011 0.90 LRRK2 (0.62) LRRK2CYP3A4SLCO1B1MRGPRX4MEN1
SCHEMBL1316513 0.89 LRRK2 (0.63) LRRK2CYP3A4SLCO1B1MEN1KMT2A
SCHEMBL1317670 0.89 LRRK2 (0.66) LRRK2CYP3A4SLCO1B1MRGPRX4MEN1
SCHEMBL550991 0.88 LRRK2 (0.58) LRRK2CYP3A4SLCO1B1MRGPRX4MEN1
SCHEMBL552232 0.86 LRRK2 (0.63) LRRK2CYP3A4SLCO1B1MRGPRX4MEN1
SCHEMBL1647420 0.83 HSD17B10 (0.70) MEN1KMT2AKDM4EAPPHPGD
SCHEMBL1644930 0.82 MAPT (0.57) MEN1KMT2AKDM4ESMN1; SMN2ALDH1A1
SCHEMBL12121402 0.82 MAPT (0.55) MRGPRX4MEN1KMT2AKDM4ESMN1; SMN2
SCHEMBL4295800 0.81 MAPT (0.61) LRRK2CYP3A4SLCO1B1MEN1KMT2A
SCHEMBL1647314 0.81 MAPT (0.62) MEN1KMT2AKDM4EHPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102333757-B N-acyl anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO LTD 2014-11-26 CN disclosed
US-8492582-B2 N-acyl anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2013-07-23 US disclosed
US-20110275797-A1 N-ACYL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2011-11-10 US disclosed
EP-2385036-A1 N-ACYL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF Toyama Chemical Co., Ltd. (JP) 2011-11-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110275797-A1 N-ACYL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF COL14A1, COL2A1, COL1A1 LRRK2 1813/4885CYP3A4 3293/4885SLCO1B1 4408/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.